Cargando…
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
Stroke is a major reason for persistent disability due to insufficient treatment strategies beyond reperfusion, leading to oligodendrocyte death and axon demyelination, persistent inflammation and astrogliosis in peri-infarct areas. After injury, oligodendroglial precursor cells (OPCs) have been sho...
Autores principales: | Werner, Luisa, Gliem, Michael, Rychlik, Nicole, Pavic, Goran, Reiche, Laura, Kirchhoff, Frank, Silva Oliveira Junior, Markley, Gruchot, Joel, Meuth, Sven G., Küry, Patrick, Göttle, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341986/ https://www.ncbi.nlm.nih.gov/pubmed/37446147 http://dx.doi.org/10.3390/ijms241310972 |
Ejemplares similares
-
Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023) -
Myelin repair is fostered by the corticosteroid medrysone specifically acting on astroglial subpopulations
por: Silva Oliveira Junior, Markley, et al.
Publicado: (2022) -
Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence
por: Manousi, Anastasia, et al.
Publicado: (2021) -
TLR4 Associated Signaling Disrupters as a New Means to Overcome HERV-W Envelope-Mediated Myelination Deficits
por: Göttle, Peter, et al.
Publicado: (2021) -
Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)